Medacta Group S.A.
MEDGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $2 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 14% | 4.6% | 12.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.3% | 66.8% | 68.5% | 67.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 28.2% | 21.4% | 26.9% | 18.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 17.4% | 11.6% | 13.2% | 7.1% |
| EPS Diluted | 3.01 | 1.76 | 1.9 | 0.91 |
| % Growth | 71% | -7.4% | 108.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | $0 |